posted
Seems like great news that should result in buying, stock not really reacting yet though....
Anyone familiar with this company? I'm gonna stay on the sidelines here and see if anything happens, if not, this release goes in the trash heap.
Millenia Hope Collaborates with Coca Cola on Malarex
In-Vivo Pilot Program Bolsters MMH-Malarex/MMH-18 Scientific Platform
MONTREAL, Aug 25, 2005 /PRNewswire-FirstCall via COMTEX/ -- Millenia Hope Inc., a biotech corporation (OTC Bulletin Board: MLHP; Berlin: MLF), announced today that, in collaboration with the Coca Cola Corporation, it is implementing a 200 patient pilot program for MMH Malarex(TM)/MMH(TM)18 at Coca Cola's facility in Guinea Conakry, Africa. This program, utilizing World Health Organization (WHO) approved protocols, is being administered by Dr. Ibrahima Sory Dialo and Dr. Soriba Cisse. Dr. Dialo administrates Coca Cola's healthcare programs and the healthcare programs of other multi-national corporations in Africa. Dr. Cisse is the Vice-President, Research and Development, for Millenia Hope. Millenia Hope has identified and enrolled the 200 malaria afflicted patients, who will participate in this pilot program, and expects it to commence imminently. Commented Mr. Leonard Stella, CEO of Millenia, "This is the first time that we are involved with a multi-national and we are very excited and grateful to have the opportunity to help alleviate the suffering of their employees."
Added Dr. Maggie Bywater, President of Millenia, "Having a closed testing environment allows us to also assess the preventive properties of MMH Malarex(TM)/MMH(TM)18, vis-a-vis the malaria parasite, in a controlled population."
There are 300-500 million malaria-infected individuals globally; three (3) million die annually, of which one (1) million are children under five (5) years of age. The average person contracts malaria two times per year in endemic regions, thus causing a great negative impact on the economies of the developing world.
About Millenia Hope
Millenia Hope develops innovative treatments and quality products that will increase the quality of life, provide tools in the fight against diseases, and promote healthier lives. Our team is committed to research and development to deliver on global medical needs and to bring hope through healthcare solutions.
Safe Harbor Statement
Certain statements made in this release may contain language describing the plans, goals, strategies, intentions, forecast and expectations of Millenia Hope that may be referred to as "forward-looking statements." Several important factors could cause actual results to differ materially from those in such forward-looking statements, and Millenia Hope could encounter unanticipated obstacles and delays in developing products, services and markets.
For more information, please contact:
Mr. Hugo Valente Tel: 514-846-5757 or 514-288-8822 Fax: 514-935-9758 http://www.milleniahope.com admin@milleniahope.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com. SOURCE Millenia Hope Inc.
CONTACT: Mr. Hugo Valente of Millenia Hope, +1-514-846-5757 or +1-514-288-8822, Fax: +1-514-935-9758, admin@milleniahope.com
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
